Latest from Retirement Villages

The 45,000 vulnerable residents living under the strictest conditions in NZ

These are the residents living under the strictest conditions in the country.

No jab, no job: The company where all new staff need Covid vaccine

Those wanting to get a job with Arvida must agree to have a Covid vaccination.

Consumer NZ critical of retirement village regulations

Some contracts risk breaching consumer law says chief executive.

Simon Wallace: Critical junction for aged care

Opinion: Sector is underfunded by an estimated $425 million per year but keeps delivering.

Arvida sales up 29 per cent after Covid lockdowns

Illness, need for a higher level of care or death - reasons for village resales

Oceania sales jump 44%, half-year profit up $9m

Listed retirement company result out today

'Overlooked': Kiwi company's shares surge 300 per cent in 10 months

Share price rise expected to continue, with its fortunes partly pegged to housing sector.

Retirement giant clocks 31% quarterly sales boost

Illness or death of residents not main reason for strong trade

Retirement village owner to repay $8.6m wage subsidy

Outgoing chairman Rob Campbell said the time was right to return the money.

Business Hub: Te Ao Māori values govern 'world-first' Tahito fund

"As soon as you do this, you become the kaitiaki of these values." - Temuera Hall.

'Milestone' day as $1.2b Metlifecare delists tonight

Glen Sowry thanked the board and shareholders 'for their service and support'.

Neighbours take on Ryman over $150m plan

Residents worry about buildings' height, barrister says developers 'not the bad guys'.

Investor in Metlifecare tries to block $1.27b deal

Company 'considering notice of opposition'

What next for Metlifecare after $1.27b takeover?

Super Fund expresses satisfaction with result.

$130 million development begins on volcanic crater rim

This is one of the biggest projects on the books for Oceania Healthcare.

Metlifecare shareholders approve $1.27b takeover

Hard questions put to board over controversial takeover offer.

Fund manager opposes $1.27b Metlifecare takeover

"Discount relative to its peers excessive" - Matthew Goodson.

NZ Super Fund to quit Metlifecare at $6 a share

Fund backs majority of directors, in favour of share price offer.